Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ryota Tanaka"'
Autor:
Yu, Maeda, Ryota, Tanaka, Ryosuke, Tatsuta, Kuniko, Takano, Takehiro, Hashimoto, Masao, Ogata, Kazufumi, Hiramatsu, Hiroki, Itoh
Publikováno v:
Biological and Pharmaceutical Bulletin. 45:1084-1090
The pharmacokinetics of voriconazole shows large intra-individual and inter-individual variability and is affected by various factors. Recently, inflammation has been focused as a significant factor affecting the variability. This study aimed to comp
Autor:
Norihisa Yasuda, Yoshifumi Ohchi, Koji Goto, Hiroki Itoh, Yosuke Suzuki, Ryota Tanaka, Takaaki Kitano, Daiki Eto, Ryosuke Tatsuta
Publikováno v:
Biological and Pharmaceutical Bulletin. 44:737-741
For intensive care unit (ICU) patients, injectable voriconazole (VRCZ) is difficult to use because the patients often develop acute kidney injury. Since many ICU patients have consciousness disturbance, oral ingestion of tablet formulation is also di
Publikováno v:
YAKUGAKU ZASSHI. 139:917-922
The use of a drug administration plan and therapeutic drug monitoring (TDM) based on pharmacokinetic-pharmacodynamic (PK-PD) analysis is important for the effective use of antimicrobial agents to treat infections. We focused on the use of beta-lactam
Autor:
Haruhiko Kondo, Kazuhiro Watanabe, Yoko Nakazato, Ryota Tanaka, Hidefumi Takei, Keisei Tachibana, Reisuke Seki, Yoshihito Morimoto, Yasushi Nagashima, Takao Shinohara
Publikováno v:
YAKUGAKU ZASSHI. 138:437-442
Adjuvant cisplatin-vinorelbine chemotherapy has been shown to be effective in patients with completely resected non-small cell lung cancer (NSCLC) in several Phase III trials, but not yet in the Japanese population. Pharmacists are expected to assist
Autor:
Hiroki Itoh, Ko Nonoshita, Yoshifumi Ohchi, Tamio Ueno, Shusaku Kurogi, Yuhki Sato, Norihisa Yasuda, Yosuke Suzuki, Ito Kentaro, Koji Goto, Tetsuya Kaneko, Ryota Tanaka
Publikováno v:
Biological & Pharmaceutical Bulletin. 40:1226-1231
Doripenem (DRPM) is a broad-spectrum antibacterial agent often used as empirical therapy for critically ill patients, although there is a lack of studies validating the recommended dosage regimen for patients admitted to intensive care unit (ICU), ba